kynurenine has been researched along with Mast Cell Activation Disease in 2 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mastocytosis is a heterogeneous disease characterized by mast cell accumulation in various tissues with 57% of patients having gastrointestinal involvement." | 5.43 | Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms. ( Barète, S; Canioni, D; Chandesris, MO; Côté, F; Damaj, G; Dubreuil, P; Georgin-Lavialle, S; Hanssens, K; Hermine, O; Launay, JM; Lortholary, O; Moura, DS; Sokol, H; Soria, A; Soucié, E, 2016) |
| "Mastocytosis is a rare disease in which chronic symptoms, including depression, are related to mast cell accumulation and activation." | 1.43 | Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis. ( Alyanakian, MA; Aouba, A; Bachmeyer, C; Barète, S; Bonin, B; Chandesris, MO; Chauvet-Gelinier, JC; Côté, F; Damaj, G; Dubreuil, P; Gaillard, R; Georgin-Lavialle, S; Grandpeix-Guyodo, C; Haffen, E; Hermine, O; Launay, JM; Lortholary, O; Moura, DS; Salvador, A; Soucié, E; Teyssier, JR; Trojak, B; Vandel, P, 2016) |
| "Mastocytosis is a heterogeneous disease characterized by mast cell accumulation in various tissues with 57% of patients having gastrointestinal involvement." | 1.43 | Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms. ( Barète, S; Canioni, D; Chandesris, MO; Côté, F; Damaj, G; Dubreuil, P; Georgin-Lavialle, S; Hanssens, K; Hermine, O; Launay, JM; Lortholary, O; Moura, DS; Sokol, H; Soria, A; Soucié, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgin-Lavialle, S | 2 |
| Moura, DS | 2 |
| Salvador, A | 1 |
| Chauvet-Gelinier, JC | 1 |
| Launay, JM | 2 |
| Damaj, G | 2 |
| Côté, F | 2 |
| Soucié, E | 2 |
| Chandesris, MO | 2 |
| Barète, S | 2 |
| Grandpeix-Guyodo, C | 1 |
| Bachmeyer, C | 1 |
| Alyanakian, MA | 1 |
| Aouba, A | 1 |
| Lortholary, O | 2 |
| Dubreuil, P | 2 |
| Teyssier, JR | 1 |
| Trojak, B | 1 |
| Haffen, E | 1 |
| Vandel, P | 1 |
| Bonin, B | 1 |
| Hermine, O | 2 |
| Gaillard, R | 1 |
| Soria, A | 1 |
| Canioni, D | 1 |
| Hanssens, K | 1 |
| Sokol, H | 1 |
2 other studies available for kynurenine and Mast Cell Activation Disease
| Article | Year |
|---|---|
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.
Topics: Depression; Depressive Disorder, Major; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflam | 2016 |
Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.
Topics: Biomarkers; Case-Control Studies; Digestive System; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxyge | 2016 |